OSTX Earnings Date & History
OS Therapies Inc (NYSE MKT LLC) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:19 PM ET
OS Therapies Inc
Biotechnology
- Next earnings date
- Not scheduled
- Reporting session
- —
- EPS estimate
- —
- Revenue estimate
- —
OSTX earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Monday, May 18, 2026 | Q1 2026 | $-0.18 | $-0.27 | -49.8% | $0 |
| Tuesday, March 31, 2026 | Q4 2025 | $-0.14 | $-0.50 | -260.5% | $0 |
| Friday, November 14, 2025 | Q3 2025 | $-0.13 | $-0.21 | -64.7% | $0 |
| Monday, August 18, 2025 | Q2 2025 | $-0.12 | $-0.19 | -62.0% | $0 |
What the market is watching in OSTX's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next OSTX earnings date?
- OS Therapies Inc has not confirmed its next reporting date yet. This page updates automatically once the date is scheduled.
- Does OSTX report before or after the market?
- The reporting session is published with the confirmed date; recent quarters are listed in the history table on this page.
- What EPS is expected for OSTX?
- Analyst estimates for the upcoming quarter have not been published yet.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
OSTX earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.